Ketotifen Fumarate/Naphazoline Hydrochloride

富马酸酮替芬/盐酸萘甲唑啉

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKetotifen Fumarate/Naphazoline Hydrochloride
Drug Alias NameKetotifen fumarate/naphazoline HCl萘甲唑啉+酮替芬酮替芬+萘甲唑啉Ketotifen Fumarate+Naphazoline Hydrochloride萘甲唑啉/酮替芬 +[12] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsAlpha adrenergic receptor agonists
TargetsHistamine H1 receptorAlpha adrenergic receptor
Therapy Area/IndicationsConjunctivitis, Allergic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Naphazoline HydrochlorideKetotifen Fumarate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBausch & Lomb
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBausch & Lomb
Active IndicationsN/A
Inactive IndicationsConjunctivitis, Allergic

Other Information

ATC CodeN/A
Related LinksKEGG